← Evidence map

ArticlePloS one2026

The METTL3 inhibitor STM2457 suppresses gastric cancer progression by modulating m6A RNA modification.

Hang Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41875089